Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
REGEnLIFE tests light stimulation on neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases

The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis

13th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2019, Lisbon

Guillaume Blivet, Laura Auboyer, Johann Meunier, Laura Ceolin, François J. Roman, Rémy Burcelin, Jacques Touchon.

Share this article